Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Statement of Cash Flows [Abstract]    
NET CASH PROVIDED BY OPERATING ACTIVITIES $ 4,204 $ 4,765
INVESTING ACTIVITIES    
Purchase of medical equipment and property (7,168) (3,396)
Proceeds from sale of medical equipment and property 5,193 2,808
NET CASH USED IN INVESTING ACTIVITIES (1,975) (588)
FINANCING ACTIVITIES    
Principal payments on revolving credit facility, term loans, and capital lease obligations (49,101) (27,912)
Cash proceeds from revolving credit facility 47,814 22,395
Common stock repurchased to satisfy statutory withholding on employee stock based compensation plans (178) (78)
NET CASH USED IN FINANCING ACTIVITIES (1,465) (5,595)
Net change in cash and cash equivalents 764 (1,418)
Cash and cash equivalents, beginning of period 1,138 2,326
Cash and cash equivalents, end of period $ 1,902 $ 908